Gregory W. Peet
Boehringer Ingelheim (Brazil)(BR)Boehringer Ingelheim (France)(FR)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Phagocytosis and Immune Regulation, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, NF-κB Signaling Pathways
Most-Cited Works
- → Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma(2019)1,619 cited
- → IKKα, IKKβ, and NEMO/IKKγ Are Each Required for the NF-κB-mediated Inflammatory Response Program(2002)223 cited
- → Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition(2001)154 cited
- → The kinetics of binding to p38 MAP kinase by analogues of BIRB 796(2003)111 cited
- → Discovery and Characterization of a Substrate Selective p38α Inhibitor(2004)110 cited
- → IκB Kinases α and β Show a Random Sequential Kinetic Mechanism and Are Inhibited by Staurosporine and Quercetin(1999)102 cited
- → Recombinant IκB Kinases α and β Are Direct Kinases of IκBα(1998)70 cited
- → Discovery of 2-Phenylamino-imidazo[4,5-h]isoquinolin-9-ones: A New Class of Inhibitors of Lck Kinase(2002)63 cited
- → The discovery of carboline analogs as potent MAPKAP-K2 inhibitors(2007)58 cited
- → Catalysis and Function of the p38α·MK2a Signaling Complex(2004)51 cited